The idea to question
A medicine is either covered for everyone or covered for nobody.
The short answer
Part D is Medicare’s usual prescription medicine cover. In September 2026, Part D does not cover a medicine used for weight loss alone. Another accepted medical purpose may allow cover for that medicine. Treating type 2 diabetes is one example; reducing certain heart risks is another. CMS’s explanation of the coverage rule
Eligible for coverage does not mean paid
The Centers for Medicare & Medicaid Services (CMS) explains the rule as of September 2026. Payment still depends on your particular plan. It uses its own medicine list and may need to agree to payment before you get the prescription filled. CMS’s explanation of the coverage rule
Ask the plan about your exact medicine and use. Request the answer in writing, including what remains for you to pay.
Keep a temporary programme separate
Your body makes chemical messages called hormones. GLP-1 is one such message, affecting appetite and blood sugar. Some medicines act like GLP-1. Mounjaro and Zepbound are examples containing tirzepatide; Ozempic and Wegovy contain semaglutide.
The temporary Medicare GLP-1 Bridge began July 1, 2026. Its planned end is December 31, 2027, according to CMS as of September 2026. It gives eligible people a monthly medicine share, called a copay, of $50. CMS’s temporary bridge programme
The Bridge pays through a separate temporary programme, outside normal Part D cover. That is why some people can pay $50 even though the Part D rule still excludes weight-loss use. CMS’s temporary bridge programme
Qualifying for the Bridge depends on your age, weight, health conditions and Medicare plan. Having type 2 diabetes sends the payment question to normal Part D instead; it does not qualify you for the Bridge. CMS’s Bridge eligibility rules
Ask your plan and the person treating you to check which programme applies and what you would pay.